top of page
What We Do
GENOMIC ANALYTICS THAT ENABLES BETTER DRUG DEVELOPMENT, DISEASE DIAGNOSIS AND PATIENT TREATMENT


Oncology
Providing analytics that identify responders versus non-responders to immunotherapy treatment and predicting cancer progression

Cognitive Impairment
Early detection and better categorisation of Alzheimer's and Parkinsons disease to assist in delaying onset

Genomic Data Services
Optimising drug development and improving clinical trial design and outcomes
Point of Difference

How we do it

bottom of page